12 Week Study of Anti-Viral Effect of Oral UT-231B in Non-cirrhotic Hepatitis C Patients who have Failed Interferon-based Therapy.

NCT00069511 · clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
72
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

United Therapeutics